128 related articles for article (PubMed ID: 791316)
21. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
Li BY; Bai Y; Li WH
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibitory effects of chlorpromazine and imipramine on platelet aggregation.
Ishigooka J; Tanaka K; Suzuki Y; Katori M; Miura S
Int Pharmacopsychiatry; 1980; 15(5):270-80. PubMed ID: 7263149
[TBL] [Abstract][Full Text] [Related]
23. Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
Dinan TG
Psychol Med; 1987 Nov; 17(4):875-81. PubMed ID: 2893407
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the equine platelet aggregation response.
Meyers KM; Lindner C; Grant B
Am J Vet Res; 1979 Feb; 40(2):260-4. PubMed ID: 464363
[TBL] [Abstract][Full Text] [Related]
25. Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine.
Boullin DJ; Glenton PA
Br J Pharmacol; 1978 Apr; 62(4):537-42. PubMed ID: 26445
[TBL] [Abstract][Full Text] [Related]
26. Induction of platelet aggregation in vitro by microbubbles of nitrogen.
Thorsen T; Lie RT; Holmsen H
Undersea Biomed Res; 1989 Nov; 16(6):453-64. PubMed ID: 2603242
[TBL] [Abstract][Full Text] [Related]
27. Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients.
McAdams C; Leonard BE
Int Clin Psychopharmacol; 1992 Nov; 7(2):81-5. PubMed ID: 1487625
[TBL] [Abstract][Full Text] [Related]
28. [Modulating effects of adenosine on the process of human platelet activation].
Prokudin VIu; Melkova OM; Karaulov AV; Porodenko NV
Biull Eksp Biol Med; 1992 Jun; 113(6):606-8. PubMed ID: 1446028
[TBL] [Abstract][Full Text] [Related]
29. Blunted serotonergic responsivity in neuroleptic-naïve patients at first-episode of schizophrenia.
Reddy R; Keshavan M; Yao JK
Schizophr Res; 2007 Feb; 90(1-3):81-5. PubMed ID: 17204398
[TBL] [Abstract][Full Text] [Related]
30. Abnormal platelet aggregation in patients with Raynaud's phenomenon.
Biondi ML; Marasini B
J Clin Pathol; 1989 Jul; 42(7):716-8. PubMed ID: 2760232
[TBL] [Abstract][Full Text] [Related]
31. Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression.
Gómez-Gil E; Gastó C; Díaz-Ricart M; Carretero M; Salamero M; Catalán R; Escolar G
Hum Psychopharmacol; 2002 Dec; 17(8):419-24. PubMed ID: 12457378
[TBL] [Abstract][Full Text] [Related]
32. Effects of chlorpromazine on serotonin uptake in blood platelets.
Arora RC; Meltzer HY
Psychiatry Res; 1983 May; 9(1):23-8. PubMed ID: 6577481
[TBL] [Abstract][Full Text] [Related]
33. 5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats.
Awabdy D; Bryan-Lluka LJ; Wanstall JC
Eur J Pharmacol; 2003 Jan; 459(1):1-7. PubMed ID: 12505528
[TBL] [Abstract][Full Text] [Related]
34. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
Hourani SM; Hall DA; Nieman CJ
Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
[TBL] [Abstract][Full Text] [Related]
35. MAO activity, serotonin metabolism and aggregation of platelets from migraine patients. A preliminary study.
Kovács K; Tóthfalusi L; Hermán F; Magyar K
Pol J Pharmacol Pharm; 1988; 40(6):691-5. PubMed ID: 3152004
[TBL] [Abstract][Full Text] [Related]
36. The comparison between ADP-induced aggregation and noradrenaline plus 5-hydroxytryptamine induced aggregation.
Takano S; Suzuki T
Fukushima J Med Sci; 1978 Feb; 25(1-2):1-7. PubMed ID: 748135
[No Abstract] [Full Text] [Related]
37. Proceedings: Time-dependent potentiation and inhibition by 5-hydroxytryptamine of platelet aggregation induced by ADP.
Michal F; Motamed M
Br J Pharmacol; 1975 Jun; 54(2):221P-222P. PubMed ID: 1148513
[No Abstract] [Full Text] [Related]
38. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM
Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of platelet thrombus formation by chlorpromazine acting to diminish haemolysis.
Born GV; Wehmeier A
Nature; 1979 Nov; 282(5735):212-3. PubMed ID: 492337
[TBL] [Abstract][Full Text] [Related]
40. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
Nunn B
Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
